org placeholder image

Yanwen Fu

Executive Director, Antibody Drug Conjugate R&D, Chemical Immunotherapy at Sorrento Therapeutics

  • LinkedIn
map
SORRENTO THERAPEUTICS

SORRENTO THERAPEUTICS

  • description Description
    Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical needs. O...

    Read More

  • Employees count Employees 501-1000
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Sorrento Therapeutics Org Chart and Mapping

Employees

Yi Sui

Quality Control Manager

Ysenia Lopez

Manufacturing Technician

Laurie Rosenberg

Head, Clinical Operations

Alexis Nahama

SVP Corporate Development, Head of Pain and Inflammation Bu, Head of Brazil Operations.

Frequently Asked Questions Regarding Yanwen Fu

Answer: Yanwen Fu works for Sorrento Therapeutics as Executive Director, Antibody Drug Conjugate R&D, Chemical Immunotherapy

Answer: Yanwen Fu’s role in Sorrento Therapeutics is Executive Director, Antibody Drug Conjugate R&D, Chemical Immunotherapy

Answer: Yanwen Fu's email address is y***@gmail.com

Answer: Yanwen Fu's business email address is y****@sorrentotherapeutics.com

Answer: Yanwen Fu’s direct phone number is (***)-***-****

Answer: Yanwen Fu works in the industry of: Biotechnology

Answer: Yanwen Fu works Sorrento Therapeutics located at 4955 Directors Pl, San Diego, California, 92121, United States

Answer: Sorrento Therapeutics's Executive Director, Antibody Drug Conjugate R&D, Chemical Immunotherapy is Yanwen Fu

Answer: Yanwen Fu contact details:

  • Phone number  :  (***)-***-****
  • Email  :  y****@sorrentotherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access